Yes, 120 mg of Prozac daily is likely contributing to this patient's chronic constipation, though this is an unusually high dose for an adolescent.
Dose Concerns
This 120 mg daily dose is double the maximum recommended dose for adolescents. According to GLAD-PC guidelines, the maximum dosage of fluoxetine for adolescents with depression is 60 mg daily, with an effective dose typically around 20 mg 1. This patient is receiving twice the guideline-recommended maximum, which significantly increases the risk of adverse effects including gastrointestinal symptoms.
Constipation as an Adverse Effect
While SSRIs are commonly associated with gastrointestinal side effects, constipation is actually less common with fluoxetine compared to other antidepressants. A 1988 study comparing fluoxetine to imipramine found that fluoxetine was associated with fewer complaints of constipation than tricyclic antidepressants 2. The American College of Physicians guideline notes that constipation is among the commonly reported adverse events with second-generation antidepressants, though it varies by agent 3.
Paradoxical Evidence
Interestingly, recent research shows fluoxetine can actually improve constipation in specific contexts:
- Fluoxetine significantly increased bowel movement frequency in patients with constipation-predominant IBS 4
- A 2025 study found fluoxetine effective for functional constipation with somatic symptom disorder, with 40% of patients achieving ≥3 complete spontaneous bowel movements per week 5
- Another 2025 study demonstrated fluoxetine relieved CUMS-induced constipation by restoring serotonin signaling and improving gut motility 6
Clinical Interpretation
The constipation in this patient is more likely related to the excessive dose rather than fluoxetine's typical pharmacological effects. At 120 mg daily, the patient experiences:
- Significantly elevated plasma concentrations (the FDA label notes concentrations of 91-302 ng/mL at just 40 mg/day) 7
- Accumulation of both fluoxetine and its active metabolite norfluoxetine due to their long half-lives (4-6 days and 4-16 days respectively) 7
- Increased risk of serotonin toxicity and other adverse effects at supratherapeutic levels
Recommended Action
Immediately consult with the prescribing psychiatrist to review this dose. The dose should be reduced to ≤60 mg daily per adolescent guidelines 1. Given fluoxetine's long half-life, plasma concentrations will remain elevated for weeks even after dose reduction 7. Monitor for improvement in constipation symptoms 4-6 weeks after dose adjustment, as this allows time for steady-state concentrations to equilibrate at the lower dose.
Common pitfall: Do not abruptly discontinue fluoxetine, as all SSRIs require slow tapering to avoid withdrawal effects 1. Work collaboratively with the prescribing physician rather than independently adjusting psychiatric medications.